Home » Stocks » GBLX

GB Sciences, Inc. (GBLX)

Stock Price: $0.0751 USD -0.0049 (-6.13%)
Updated Feb 26, 2021 3:54 PM EST - Market closed
Market Cap 22.04M
Revenue (ttm) 1.34M
Net Income (ttm) -11.87M
Shares Out 280.97M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 26
Last Price $0.0751
Previous Close $0.0800
Change ($) -0.0049
Change (%) -6.13%
Day's Open 0.0880
Day's Range 0.0750 - 0.0880
Day's Volume 418,685
52-Week Range 0.0151 - 0.13

News

Accesswire - 1 month ago

LAS VEGAS, NV / ACCESSWIRE / January 12, 2021 / GB Sciences, Inc. (OTCQB:GBLX) completed the sale of its remaining interest in GB Sciences Louisiana LLC ("GBSLA") on December 16, 2020. In Nove...

About GBLX

GB Sciences engages in the research and development of cannabinoid medicines in North America and Europe. Its intellectual property covers a range of conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, and cardiovascular therapeutic programs. The company was formerly known as Growblox Sciences, Inc. and changed its name to GB Sciences, Inc. in October 2016. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada.

Industry
Biotechnology
CEO
John Poss
Employees
23
Stock Exchange
OTCMKTS
Ticker Symbol
GBLX
Full Company Profile

Financial Performance

In 2019, GB Sciences's revenue was $3.12 million, a decrease of -9.67% compared to the previous year's $3.45 million. Losses were -$12.37 million, -47.69% less than in 2018.

Financial Statements